Navigation Links
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
Date:9/4/2013

opment and/or FDA approval of our product candidates, including as a result of the need to conduct additional studies, or the failure to obtain such approval of our product candidates, including as a result of changes in regulatory standards or the regulatory environment during the development period of any of our product candidates; uncertainties in clinical trial results or the timing of such trials, resulting in, among other things, an extension in the period over which we recognize deferred revenue or our failure to achieve milestones that would have provided us with revenue; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products, including our dependence on AstraZeneca for the sales and marketing of VIMOVO®; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events, including those discussed herein and in our Quarterly Report on Form 10-Q for the period ended March 31, 2013. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.Contact:Sanofi USCarrie Brown(908) 981 6486Carrie.brown@sanofi.com POZEN Inc.Bill Hodges

Stephanie BonestellChief Financial Officer

Manager, Investor Relations and Public Relations(919) 913 1030

(919) 913 1030

SOURCE Sanofi US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
2. Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
3. Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
4. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
7. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. NextBio Announces Translational Medicine Partnership with Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
(Date:1/14/2014)... , Jan. 14, 2014 Animal Emergency Critical Care, a ... Leesburg, Virginia is the first in ... chamber. Dr. Susan M. Barnes , Medical ... Barnes and husband, Dr. Cole Taylor , are avid scuba ...
(Date:1/14/2014)... , January 14, 2014 ... Transfer Devices (CSTD) for hazardous drugs, today announced that it ... fourth straight year.   Equashield,s closed ... technicians, pharmacists, nurses and other medical professionals who ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... 9 BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today ... the Company,s Board of Directors. Dr. Sanders brings to ... and professor of medicine. , "We are pleased ... Zola P. Horovitz, Ph.D., Chairman of the Board of BioCryst ...
... , LONDON, Dec. 9 ... $1 billion in the European Union (EU), which includes total ... anticholinergics used for disease symptom relief. With the introduction of ... guidelines that call for using dopamine agonists as first-line therapy, ...
Cached Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3
(Date:7/9/2014)... occurrence of allergic diseases has risen dramatically in Western ... less exposed to microorganisms and have fewer infections than ... , A study by researchers at Sahlgrenska Academy, University ... to examine maturation of the immune system in relation ... rural areas of the Vstra Gtaland Region, half of ...
(Date:7/8/2014)... UCLA Program in Memory Restoration has been awarded up ... Agency (DARPA) for a four -year project aiming to ... team of experts in neurosurgery, engineering, neurobiology, psychology and ... a memory prosthesis in the brain. , Memory is ... the brain encode information, store it and retrieve it. ...
(Date:7/8/2014)... hygiene rates were found to be three times higher ... there were no auditors present, according to a study ... The study, titled, "Quantification of the Hawthorne effect in ... a retrospective cohort study," published today on-line in the ... author Dr. Jocelyn Srigley, who did the study as ...
(Date:7/8/2014)... have increased risks of dying at a young age ... stroke, diabetes, and kidney and liver diseases, according to ... large studies of people from three countries. The study, ... part of the National Institutes of Health, found that ... dramatic reduction in life expectancy compared with people of ...
(Date:7/8/2014)... LOUIS Military physicians will soon pick up joysticks instead ... children with serious health threats. , James Gerard, M.D., a ... $541,807 grant from the Department of Defense Office of ... develop a video game that will train physicians on pediatric ... to use one of the most popular tools gaming ...
Breaking Medicine News(10 mins):Health News:DARPA awards UCLA $15 million to restore lost memory 2Health News:DARPA awards UCLA $15 million to restore lost memory 3Health News:Health-care worker hand hygiene rates increase three-fold when auditors visible 2Health News:Health-care worker hand hygiene rates increase three-fold when auditors visible 3Health News:NCI study finds extreme obesity may shorten life expectancy up to 14 years 2Health News:Save, don't kill: SLU pediatrician to develop educational video game for training military physician 2
... MONDAY, Dec. 19 (HealthDay News) -- When it comes to toys, ... for parents, who find themselves asking two crucial questions. The ... safe for my child? And the second, though not as ... media aimed at spurring a child,s development: Which of these toys ...
... EDITOR,S PICK: Potential concern about drugs in clinical trial ... derived naturally in the body from a major component ... [EETs]) are currently in clinical trials for the treatment ... researchers led by Dipak Panigrahy and Mark Kieran, ...
... COLUMBUS, Ohio -- Drinking enough alcohol to become intoxicated increases ... according to new research. But people without that trait ... when they,re sober. That trait is the ability to ... focus on the here and now, without thinking about the ...
... 19 (HealthDay News) -- Knee pain is common in middle-aged and ... of data collected from nearly 500 women, ages 44 to 57, ... older reported persistent, incident or intermittent knee pain. Forty-four percent ... percent said they had knee pain on most days of the ...
... Known for her poetry, letters, love affair and marriage ... legacy of unanswered questions about her lifelong chronic illness. ... her daughter, may have unraveled the mystery. Born in ... weakness, heart palpitations, intense response to heat and cold, ...
... better quality of life (QOL) and diminished cardiovascular disease ... adenotonsillectomy, according to new research published in the December ... Surgery . SDB is an increasingly common ... apnea syndrome (OSAS). Cardiovascular (CV) disease frequently has been ...
Cached Medicine News:Health News:Discerning Gift-Givers Look for Toys That Offer More Than Fun 2Health News:Discerning Gift-Givers Look for Toys That Offer More Than Fun 3Health News:Discerning Gift-Givers Look for Toys That Offer More Than Fun 4Health News:JCI online early table of contents: Dec. 19, 2011 2Health News:JCI online early table of contents: Dec. 19, 2011 3Health News:JCI online early table of contents: Dec. 19, 2011 4Health News:JCI online early table of contents: Dec. 19, 2011 5Health News:JCI online early table of contents: Dec. 19, 2011 6Health News:JCI online early table of contents: Dec. 19, 2011 7Health News:1 trait has huge impact on whether alcohol makes you aggressive 2Health News:1 trait has huge impact on whether alcohol makes you aggressive 3Health News:Knee Pain Plagues Many Women Over 50 2Health News:Elizabeth Barrett Browning's illness deciphered after 150 years 2Health News:Elizabeth Barrett Browning's illness deciphered after 150 years 3Health News:Effect of adenotonsillectomy in children with sleep-disordered breathing 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: